News Releases
Prometheus Biosciences Reports Third Quarter 2022 Financial Results and Highlights Recent Corporate Progress
Nov 09, 2022
Prometheus Biosciences Receives FDA Clearance of IND Application for its Second Precision Program, PRA052
Oct 03, 2022
Prometheus Biosciences Reports Second Quarter 2022 Financial Results and Highlights Recent Corporate Progress
Aug 11, 2022
Prometheus Biosciences to Host a Virtual R&D Day for Analysts and Investors on July 26, 2022
Jul 18, 2022
Prometheus Biosciences Completes Enrollment of the ARTEMIS-UC Cohort 1 Phase 2 Study in Ulcerative Colitis
Jul 18, 2022
Displaying 11 - 20 of 53